| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
| 05/23/2001 | EP1100964A1 Gene sequence variances with utility in determining the treatment of disease |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
| 05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100827A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 05/23/2001 | EP1100823A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 05/23/2001 | EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100526A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100515A1 $i(EX VIVO) TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100486A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100484A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100483A2 Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | EP1100465A1 Medicinal aerosol formulations |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP0683784B1 7,42-bis (o-demethyl) rapamycin |
| 05/23/2001 | EP0669827B1 Compositions for the regulation of cytokine activity |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296529A Method for screening therapeutic agents |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296416A Adjuvant compositions |
| 05/23/2001 | CN1296415A IL-12 stimulation of neonatal immunity |
| 05/23/2001 | CN1296414A IL-12 enhancement of immune responses to T-isdependent antigens |
| 05/23/2001 | CN1296406A Pharmaceutial compositions |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/22/2001 | US6235760 Treatment for CNS injuries |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones |
| 05/22/2001 | US6235739 5-phenyl-3-pyridazinone derivatives and drug composition containing the same |
| 05/22/2001 | US6235733 Aids therapy |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235727 Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene |
| 05/22/2001 | US6235282 Vaccinal fluid water-in-oil emulsions containing a metabolizable oil |
| 05/22/2001 | US6235281 Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/17/2001 | WO2001034828A1 Process for producing tripeptides |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034709A1 Dye labeled imidazoquinoline compounds |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034645A2 Mutated il-13 molecules and their uses |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034193A1 Plant lectins as mucosal adjuvants |
| 05/17/2001 | WO2001034192A2 Improved method of immunization |
| 05/17/2001 | WO2001034189A2 Vaccines for mycoplasma bovis and methods of use |
| 05/17/2001 | WO2001034186A1 Compositions and methods for modifying an immune response against tropomyosin |
| 05/17/2001 | WO2001034185A2 Induction of mucosal immunity by vaccination via the skin route |
| 05/17/2001 | WO2001034170A2 Phytotherapeutic composition |
| 05/17/2001 | WO2001034152A1 Nasal drops containing fused pyridazine derivatives |
| 05/17/2001 | WO2001034141A1 Il-8 receptor antagonists |
| 05/17/2001 | WO2001034138A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | WO2001034095A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 05/17/2001 | WO2001033975A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |